ArticleBMC cancer2011
Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population.
Article in BMC cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries.BMC medical research methodology · 2022Pooled it
- Statistical methods for measuring trends in colorectal cancer incidence in registries: A systematic review.Frontiers in oncology · 2022Pooled it
- A Systematic Literature Review and Meta-Regression Analysis on Early-Life Energy Restriction and Cancer Risk in Humans.PloS one · 2016Pooled it
- FOLFIRI® and bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms.BMC research notes · 2014Trial
- Descriptive Epidemiology of Early-Onset Gastrointestinal Cancers in Iran, 2014-2018.Middle East journal of digestive diseases · 2024Article
- The mortality risk in patients with early onset colorectal cancer: the role of comorbidities.Frontiers in oncology · 2023Article
- Trends of colorectal cancer in a central area of Iran during 2009-2014. An application of joinpoint regression.Contemporary oncology (Poznan, Poland) · 2022Article
- Targeting BRAF and RAS in Colorectal Cancer.Cancers · 2021Review
- Radiation risk of incident colorectal cancer by anatomical site among atomic bomb survivors: 1958-2009.International journal of cancer · 2020Article
- Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients.Langenbeck's archives of surgery · 2019Article
- Increasing colorectal cancer incidence in individuals aged < 50 years-a population-based study.International journal of colorectal disease · 2019Article
- Colorectal Cancer in the Young: Does Screening Make Sense?Current gastroenterology reports · 2019Review
- Establishing a research agenda for early-onset colorectal cancer.PLoS medicine · 2018Article
- PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer.Cancer medicine · 2015Article
- Microangiopathy is common in submucosal vessels of the colon in patients with diabetes mellitus.The review of diabetic studies : RDS · 2014Article
- Sporadic carcinoma of the colon-rectum in young patients: a distinct disease? A critical review.Journal of gastrointestinal cancer · 2013Review
- Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013Article
- Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study.International journal of colorectal disease · 2013Article
- Article
- How many diseases are colorectal cancer?Gastroenterology research and practice · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFrance stands among high-risk areas for colorectal cancer. Different trends in CRC incidence are reported around the world. The aim of this study was to provide temporal trends in CRC incidence over a 30-year period in a French well-defined population.
methodsBetween 1976 and 2005, 17,028 new cases were registered by the Burgundy digestive cancer registry. The mean variations in age-standardized incidence rates were estimated using a Poisson regression adjusted for age for each gender and location. The cumulative risk by birth cohort of developing a cancer over the age range 0-74 years was estimated using an age-cohort model.
resultsIncidence rates for right and left colon cancers increased more rapidly in males (respectively +11.7% and +10.3% on average by 5-year period) than in females (respectively +5.9% and +6.1%). It remained stable for sigmoid cancers in males (-0.1%) and decreased in females (-5.2%). It also decreased for rectal cancers both in males (-2.7%) and in females (-2.0%). The cumulative risk increased from 3.9% for males born around 1900 to 4.9% for those born around 1930 and then slightly decreased (4.5% among those born around 1950). It remained at the same level for females born around 1900 (2.7%) as for those born around 1930 (2.7%) and then slightly increased (2.9%) for those born around 1950. For right colon cancers, the cumulative risk increased strikingly in successive birth cohorts from 0.53% to 1.2% in males and 0.55% to 0.77% in females. The corresponding cumulative risks for the left colon were 0.24% and 0.42% in males and 0.14% and 0.29% in females. For sigmoid cancer, they decreased from 1.59% to 1.08% in males, and 0.88% to 0.80% in females.
conclusionTemporal variations in incidence rates of colorectal cancers differed according to subsite, suggesting different aetiological factors and implications for diagnosis and screening strategies. Total colonoscopy must be the preferred strategy in high-risk groups or after a positive faecal occult blood test.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.